Literature DB >> 2832334

DNA ploidy level and cell cycle distribution in ovarian cancer: relation to histopathological features of the tumor.

O P Kallioniemi1, J Mattila, R Punnonen, T Koivula.   

Abstract

We analyzed nuclear DNA content and S-phase fraction (SPF) from 157 paraffin-embedded ovarian tumors by flow cytometry and compared the results with the clinicopathological features of the tumors. DNA aneuploidy was more common and mean SPF was higher in advanced than in early-stage tumors (p less than 0.001). DNA aneuploidy was most often (75%) observed in undifferentiated tumors (World Health Organization classification) and most seldom (30%) in mucinous carcinomas. Mean SPF values ranged from 17.7% in undifferentiated carcinomas to 11.1% in mucinous carcinomas. DNA flow cytometric results correlated better with nuclear than with histological tumor grade. The proportion of DNA-aneuploid tumors increased from 30% in nuclear grade I to 93% in nuclear grade III, and mean SPF increased from 9.9 to 20.2% (p less than 0.001). DNA ploidy and SPF were independently associated with both stage and nuclear grade of the tumor, whereas the differences between the histopathological tumor types virtually disappeared when the groups were adjusted for nuclear grade. On the basis of these clinicopathological correlations, it appears that DNA ploidy and SPF reflect the malignant potential of ovarian tumors and thus complement the routine histopathological evaluation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832334     DOI: 10.1097/00004347-198803000-00001

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  4 in total

1.  Error-promoting DNA synthesis in ovarian cancer cells.

Authors:  Heqiao Dai; Robert J Hickey; Jianying Liu; Robert M Bigsby; Carita Lanner; Linda H Malkas
Journal:  Gynecol Oncol       Date:  2013-07-12       Impact factor: 5.482

2.  DNA analysis, chemoresistance testing and hormone receptor levels as prognostic factors in advanced ovarian carcinoma.

Authors:  J Schneider; L Edler; W Kleine; M Volm
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

3.  Assessment of proliferative activity in ovarian neoplasms by flow and static cytometry. Correlation with prognostic features.

Authors:  P C Huettner; D S Weinberg; J M Lage
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

4.  DNA Cytometry and Nuclear Morphometry in Ovarian Benign, Borderline and Malignant Tumors.

Authors:  Amina A Gamal El Din; Manal A Badawi; Shereen E Abdel Aal; Nihad A Ibrahim; Fatma A Morsy; Nermeen M Shaffie
Journal:  Open Access Maced J Med Sci       Date:  2015-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.